Latest News | USFDA Issues Form-483 with 3 Observations to Alkem Lab's St Louis Plant
Get latest articles and stories on Latest News at LatestLY. Alkem Laboratories on Thursday said the US health regulator has issued three observations after inspecting its St Louis-based manufacturing facility.
New Delhi, Nov 10 (PTI) Alkem Laboratories on Thursday said the US health regulator has issued three observations after inspecting its St Louis-based manufacturing facility.
The US Food and Drug Administration (USFDA) had conducted a pre-approval inspection at the plant from October 31, 2022 to November 9, 2022, the drug firm said in a regulatory filing.
Also Read | Indian Army Launches Single Window Facility Named 'Veerangana Sewa Kendra' for Welfare of Veer Naris.
At the end of the inspection, the company received Form 483 with three observations, it added.
"There is no data integrity observation. This pre-Approval Inspection is part of the routine business operations and the company shall submit to US FDA within the stipulated timeline, a detailed response to close out the said observations," the company said.
Also Read | 7th Pay Commission: After DA Hike, Fitment Factor To Be Raised? Here Are Latest News Updates.
As per USFDA, Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that in its judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)